Inactivated vaccine · VDDBV0271
Note: 1 additional source trial listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.
| NCT ID | Phase | Disease / Condition |
|---|---|---|
| NCT00586469 | Approved | Influenza Vaccines |
| NCT00764998 | Phase 3 | Influenza |
| NCT01180621 | Phase 2 | Seasonal Influenza |
| NCT00232947 | Phase 3 | Influenza |
| NCT00216242 | Phase 3 | Influenza |
| NCT00966342 | Phase 1 | Influenza |
| NCT01140009 | Phase 2 | Influenza |
| NCT01001325 | Phase 3 | Influenza |
| NCT00784784 | Phase 3 | Influenza |
| NCT00505453 | Phase 3 | Influenza |
| NCT01626820 | Phase 3 | Influenza |
| NCT01153685 | Phase 3 | Influenza |
| NCT00718120 | Phase 3 | Influenza Vaccines |
| NCT00929331 | Phase 3 | Influenza, Human |
| NCT01878825 | Phase 3 | Influenza |
| NCT01389479 | Phase 3 | Influenza |